Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
BioNTech and Fosun Pharma to Supply China with mRNA-based COVID-19 Vaccine
MAINZ, GERMANY, and SHANGHAI, CHINA, December 16, 2020 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq.
Lilly makes another gene therapy play with $1B deal to buy Prevail TX
Eli Lilly has joined the ranks of big pharma companies building a position in gene therapy, paying $26.
Harper, Seidenberg's Westlake Village BioPartners reels in $500M across 2 funds
When Amgen vets Beth Seidenberg, M.
Regeneron's blood cancer hopeful odronextamab hit with FDA partial hold across several trials
The FDA has told Regeneron to hit the brakes on its experimental blood cancer drug trial over safety concerns.
Green light for UK trial of nasal coronavirus vaccine
Open Orphan and Codagenix have received approval from the UK’s independent Medicines and Healthcare Products Regulatory Agency (MHRA) to conduct a Phase I study of its COVID-19 vaccine.
Update on The University of Queensland COVID-19 vaccine
The University of Queensland (UQ) and CSL today announce that the Phase 1 trial of the UQ-CSL v451 COVID-19 vaccine has shown that it elicits a robust response towards the virus and has a stro...
Trial of ruxolitinib in COVID-19 complications fails - Novartis
ZURICH (Reuters) - Novartis said a late-stage clinical trial of ruxolitinib on top of standard therapy showed no significant reduction in severe complications of COVID-19, including death, res...
Coronavirus: US begins vaccine shipments
The United States has kicked off a massive logistical effort to distribute coronavirus vaccines across the country.
AstraZeneca to buy Alexion Pharmaceuticals for $39bn
AstraZeneca has agreed to acquire US-based biopharmaceutical company Alexion Pharmaceuticals in a deal valued at $39bn.
Boehringer gets into 'guided-missile drugs' with $1.5 billion deal for NBE
ZURICH (Reuters) - Boehringer Ingelheim is paying 1.
Covid: Canada latest country to approve Pfizer-BioNTech vaccine
Canada's health regulator has approved the Pfizer-BioNTech Covid-19 vaccine, the day after the UK became the first country in the world to roll it out.
Researchers identify the physical mechanism that can kill bacteria with gold nanoparticles
Finding alternatives to antibiotics is one of the biggest challenges facing the research community.
285
286
287
288
289
290
291
292
293
